Evidence map›Paper›PMID 33043109›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)2020

Effects of lighting variability on locomotion in posterior cortical atrophy.

Keir X X Yong, Ian D McCarthy, Teresa Poole, Dilek Ocal, Ayako Suzuki, Tatsuto Suzuki, Kyriaki Mengoudi, Nikolaos Papadosifos, Derrick Boampong, Nick Tyler and 2 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Diagnosis and Management of Posterior Cortical Atrophy.Current treatment options in neurology · 2023
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Keir X X YongDementia Research Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK.
Ian D McCarthyPedestrian Accessibility and Movement Environment Laboratory Department of Civil, Environmental and Geomatic Engineering Faculty of Engineering Science University College London London UK.
Teresa PooleDementia Research Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK.
Dilek OcalDementia Research Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK.
Ayako SuzukiPedestrian Accessibility and Movement Environment Laboratory Department of Civil, Environmental and Geomatic Engineering Faculty of Engineering Science University College London London UK.
Tatsuto SuzukiPedestrian Accessibility and Movement Environment Laboratory Department of Civil, Environmental and Geomatic Engineering Faculty of Engineering Science University College London London UK.
Kyriaki MengoudiCentre for Medical Image Computing Department of Computer Science Faculty of Engineering Science University College London London UK.
Nikolaos PapadosifosPedestrian Accessibility and Movement Environment Laboratory Department of Civil, Environmental and Geomatic Engineering Faculty of Engineering Science University College London London UK.
Derrick BoampongPedestrian Accessibility and Movement Environment Laboratory Department of Civil, Environmental and Geomatic Engineering Faculty of Engineering Science University College London London UK.
Nick TylerPedestrian Accessibility and Movement Environment Laboratory Department of Civil, Environmental and Geomatic Engineering Faculty of Engineering Science University College London London UK.
Chris FrostDementia Research Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK.
Sebastian J CrutchDementia Research Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK.
University College London · GBUK Dementia Research Institute · GBNational Hospital for Neurology and Neurosurgery · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionClinical reports describe patients with Alzheimer's disease (AD) exhibiting atypical adaptive walking responses to the visual environment; however, there is limited empirical investigation of such behaviors or factors modulating their expression. We aim to evaluate effects of lighting-based interventions and clinical presentation (visual- vs memory-led) on walking function in participants with posterior cortical atrophy (PCA) and typical AD (tAD).

methodsParticipants with PCA (n = 10), tAD (n = 9), and healthy controls (n = 12) walked to visible target destinations under different lighting conditions within two pilot repeated-measures design investigations (Experiment 1: 32 trials per participant; Experiment 2: 36 trials per participant). Participants walked to destinations with the floorpath interrupted by shadows varying in spatial extent (Experiment 1: no, medium, high shadow) or with different localized parts of the environment illuminated (Experiment 2: target, middle, or distractor illuminated). The primary study outcome for both experimental tasks was completion time; secondary kinematic outcomes were proportions of steps identified as outliers (Experiment 1) and walking path directness (Experiment 2).

resultsIn Experiment 1, PCA participants overall demonstrated modest reductions in time taken to reach destinations when walking to destinations uninterrupted by shadows compared to high shadow conditions (7.1% reduction [95% confidence interval 2.5, 11.5; DISCUSSION: Findings represent a quantitative characterization of a clinical phenomenon involving patients misperceiving shadows, implicating dementia-related cortico-visual impairments. Results contribute to evidence-based design guidelines for dementia-friendly environments.

Indexed as

Alzheimer's diseasedementialocomotionposterior cortical atrophyvisual perception

Identifiers

PMID33043109
PMCPMC7539669
OpenAlexW3092614066

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.